Nūmi
31 employees on LinkedIn · 6 known investors
Find your way into Nūmi
Sign up to see every warm intro you have to Nūmi
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Nūmi team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Nūmi uses cell culture technology to produce a new form of nutrition, aiming to replicate the benefits of breast milk as an alternative for parents and infants, with potential applications across other age groups. It operates in the food and biotech space focused on human nutrition and health.
Investors · 6
How we know: HCVC's portfolio page · a partner's Signal profile · greenqueen.com.hk · the VCSheet dataset · Not right? Tell us
How we know: Heartcore Capital's portfolio page · a partner's Signal profile · greenqueen.com.hk · the VCSheet dataset · Not right? Tell us
Funding
SEC filings, press & company announcements- Undisclosed amountpre-seed fundingNov 2023
Financière Saint-James, HCVC, Heartcore Capital, Kima Ventures, Kost Capital
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Related companies · 4
Companies working in the same space as Nūmi.
Frequently asked questions
- What does Nūmi do?
- Nūmi uses cell culture technology to produce a new form of nutrition, aiming to replicate the benefits of breast milk as an alternative for parents and infants, with potential applications across other age groups. It operates in the food and biotech space focused on human nutrition and health.
- Who are Nūmi's investors?
- Nūmi's investors include HCVC, Heartcore Capital, Kost Capital, Sista, Financière Saint James, Kima Ventures.







